TNF and inflammatory bowel disease: In addition, Infliximab (anti-TNF-α antibody) therapy is commonly used for IBD patients, but up to one-third of the patients have been shown not to respond.65 Therefore, it was very difficult to precisely evaluate the differences in microbiota structure and biomarker levels between the subgroups.